AKT1 and Hyperglycemia: Hyperglycemia triggers intracellular pathways, which promote tumor progression, such as increased leptin levels and pro-cell survival AKT/mTOR, enhancement of WNT/βcatenin signaling, induction of epithelial mesenchymal transition and upregulation of inflammatory cytokine levels in circulation [70,71,72].